These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 27541717)
1. A Step Toward Balance: Thrombin Generation Improvement via Procoagulant Factor and Antithrombin Supplementation. Mitrophanov AY; Szlam F; Sniecinski RM; Levy JH; Reifman J Anesth Analg; 2016 Sep; 123(3):535-46. PubMed ID: 27541717 [TBL] [Abstract][Full Text] [Related]
2. Prohemostatic Activity of Factor X in Combination With Activated Factor VII in Dilutional Coagulopathy. Takeshita S; Ogawa S; Nakayama Y; Mukai N; Nakajima Y; Mizobe T; Sawa T; Tanaka KA Anesth Analg; 2019 Aug; 129(2):339-345. PubMed ID: 30320649 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic correction of thrombin generation in dilution-induced coagulopathy: computational analysis based on a data set of healthy subjects. Mitrophanov AY; Rosendaal FR; Reifman J J Trauma Acute Care Surg; 2012 Aug; 73(2 Suppl 1):S95-S102. PubMed ID: 22847103 [TBL] [Abstract][Full Text] [Related]
4. Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma. Szlam F; Taketomi T; Sheppard CA; Kempton CL; Levy JH; Tanaka KA Anesth Analg; 2008 Mar; 106(3):719-24, table of contents. PubMed ID: 18292408 [TBL] [Abstract][Full Text] [Related]
6. Controlled Multifactorial Coagulopathy: Effects of Dilution, Hypothermia, and Acidosis on Thrombin Generation In Vitro. Mitrophanov AY; Szlam F; Sniecinski RM; Levy JH; Reifman J Anesth Analg; 2020 Apr; 130(4):1063-1076. PubMed ID: 31609256 [TBL] [Abstract][Full Text] [Related]
7. Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia. Spronk HM; Braunschweig T; Rossaint R; Wüst DC; van Oerle R; Lauritzen B; Tolba R; Grottke O PLoS One; 2015; 10(6):e0113979. PubMed ID: 26098426 [TBL] [Abstract][Full Text] [Related]
8. Ex vivo coagulation test on tissue factor-expressing cells with a calibrated automated thrombogram. Takamiya O; Sakata M Lab Hematol; 2008; 14(4):39-44. PubMed ID: 19095614 [TBL] [Abstract][Full Text] [Related]
9. Utilizing Plasma Composition Data to Help Determine Procoagulant Dynamics in Patients with Thermal Injury: A Computational Assessment. Bravo MC; Tejiram S; McLawhorn MM; Moffatt LT; Orfeo T; Jett-Tilton M; Pusateri AE; Shupp JW; Brummel-Ziedins KE Mil Med; 2019 Mar; 184(Suppl 1):392-399. PubMed ID: 30901410 [TBL] [Abstract][Full Text] [Related]
10. Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation. Altman R; Scazziota A; DE Lourdes Herrera M; Gonzalez C J Thromb Haemost; 2006 Sep; 4(9):2022-7. PubMed ID: 16961610 [TBL] [Abstract][Full Text] [Related]
11. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays. Choi Q; Kim JE; Hyun J; Han KS; Kim HK Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659 [TBL] [Abstract][Full Text] [Related]
12. Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa. Bolliger D; Szlam F; Molinaro RJ; Escobar MA; Levy JH; Tanaka KA Haemophilia; 2010 May; 16(3):510-7. PubMed ID: 20050927 [TBL] [Abstract][Full Text] [Related]
13. General haemostatic agents--fact or fiction? Hedner U Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145 [TBL] [Abstract][Full Text] [Related]
14. Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions. Aljamali MN; Kjalke M; Hedner U; Ezban M; Tranholm M Haemophilia; 2009 Nov; 15(6):1318-26. PubMed ID: 19659796 [TBL] [Abstract][Full Text] [Related]
15. Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole blood. Gerotziafas GT; Depasse F; Chakroun T; Samama MM; Elalamy I Thromb Haemost; 2004 Mar; 91(3):531-7. PubMed ID: 14983229 [TBL] [Abstract][Full Text] [Related]
16. Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIa. Wegert W; Harder S; Bassus S; Kirchmaier CM Platelets; 2005 Feb; 16(1):45-50. PubMed ID: 15763896 [TBL] [Abstract][Full Text] [Related]
17. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding. Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136 [TBL] [Abstract][Full Text] [Related]
18. Factor IX from prothrombin complex concentrate augments low dose tissue factor-triggered thrombin generation in vitro. Hasan S; Abuelkasem E; Williams B; Henderson R; Mazzeffi MA; Tanaka KA Br J Anaesth; 2018 Oct; 121(4):936-943. PubMed ID: 30236256 [TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients. van Geffen M; Mathijssen NC; Holme PA; Laros-van Gorkom BA; van Kraaij MG; Masereeuw R; Peyvandi F; van Heerde WL Thromb Res; 2013 Jul; 132(1):116-22. PubMed ID: 23731565 [TBL] [Abstract][Full Text] [Related]
20. Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro. Perzborn E; Heitmeier S; Laux V; Buchmüller A Thromb Res; 2014 Apr; 133(4):671-81. PubMed ID: 24529498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]